Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
ASCO Update on Bone-Modifying Drugs in Metastatic Breast Cancer - Medscape |
![]() |
![]() |
Medscape In addition, the toxicity profiles are different — for example, denosumab is associated with a risk for hypocalcemia, and zoledronic acid and pamidronate are associated with a risk for renal toxicity and require renal function monitoring. |